Načítá se...

Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110

Ectodomains of target antigens for antibody-based therapies can be shed from the target cell surface and found in sera of patients. Shed ectodomains of therapeutic targets not only pose the risk of sequestering therapeutic antibodies but, in a multimeric form, of triggering T cell activation by bisp...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Petsch, Silke, Gires, Olivier, Rüttinger, Dominik, Denzel, Sabine, Lippold, Sandra, Baeuerle, Patrick A, Wolf, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3038009/
https://ncbi.nlm.nih.gov/pubmed/21107020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.1.14193
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!